Lyell Immunopharma

Lyell Immunopharma is one of the...

• Russell 3000.

Lyell Immunopharma is a company listed under the stock ticker LYEL (US).

View the org chart displaying its 17 main executives

Most searched biographies at Lyell Immunopharma

• Lynn Seely, Director, President and Chief Executive Officer
• Bob Nelsen, Director
• Rick Klausner, Chairman of the Board

Create your alert
to follow the executive moves at Lyell Immunopharma.

Lyell Immunopharma has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Lyell Immunopharma

• News Releases | Lyell Immunopharma, Inc.
• News Releases | Lyell Immunopharma, Inc.
• Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma | Lyell Immunopharma, Inc.
• Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023 | Lyell Immunopharma, Inc.
• News Releases | Lyell Immunopharma, Inc.
• Lyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL Manufacturing | Lyell Immunopharma, Inc.
• News Releases | Lyell Immunopharma, Inc.
• Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting | Lyell Immunopharma, Inc.
• Cellares and Lyell to Evaluate Automated Manufacturing of Lyell’s CAR T-Cell Therapy on Cellares’ Cell Shuttle Platform | Lyell Immunopharma, Inc.
• Lyell Immunopharma to Participate in Upcoming Investor Conferences | Lyell Immunopharma, Inc.
• View more press releases Close

Social media about Lyell Immunopharma

• Lyell Immunopharma on Wikipedia, Google News & Yahoo Finance
• Lyell Immunopharma on LinkedIn, Twitter & YouTube

Contact by email its executives including Lynn Seely

Call Lyell Immunopharma at +1 650...

View the org chart

Register to receive your alert

Report an error